Lifang Zhang
Ying Liu2
Xuejuan Zhang
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Department of General Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China
- 2Department of Infectious Disease, The Affiliated Hospital of Qingdao University, Qingdao, China
A Corrigendum on
A diagnostic index for predicting heart rate variability decline and prognostic value in newly diagnosed non-small cell lung cancer patients
By Zhang L, Liu Y, Han D, Wang Y, Geng F, Ding W and Zhang X (2024) Front. Oncol. 14:1463805. doi: 10.3389/fonc.2024.1463805
In the published article, there was an error. The main text contains an inconsistency with the data presented in Table 1.
A correction has been made to Results, Comparison of baseline characteristics between declined HRV group and normal HRV group, Paragraph 1. This sentence previously stated:
“The proportions of stage I, stage II, stage III, and stage IV were 1.5%, 8.4%, 55.0%, and 35.1%, respectively.”
The corrected sentence appears below:
“The proportions of stage I, stage II, stage III, and stage IV were 6.1%, 8.4%, 53.4%, and 32.1%, respectively.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: heart rate variability, non-small cell lung cancer, diagnostic index, resting heart rate, serum sodium, interleukin-6, overall survival
Citation: Zhang L, Liu Y, Han D, Wang Y, Geng F, Ding W and Zhang X (2025) Corrigendum: A diagnostic index for predicting heart rate variability decline and prognostic value in newly diagnosed non-small cell lung cancer patients. Front. Oncol. 15:1566535. doi: 10.3389/fonc.2025.1566535
Received: 25 January 2025; Accepted: 03 February 2025;
Published: 12 February 2025.
Edited and Reviewed by:
Herbert F. Jelinek, Khalifa University, United Arab EmiratesCopyright © 2025 Zhang, Liu, Han, Wang, Geng, Ding and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xuejuan Zhang, cXVhbmtlenpAMTYzLmNvbQ==; Wei Ding, dml2aWFuZGluZzIwMDVAc2luYS5jb20=